Efficacy and safety of Guhong injection for treating coronary microvascular disease: study protocol for a randomized controlled trial

DiscussionThis trial is strictly designed in accordance with principles and regulations issued by the China Food and Drug Administration (CFDA). The results should provide high-quality evidence on the efficacy and safety ofGuhong injection in the treatment of CMVD.Trial registrationChinese Clinical Trials Registry, ID:ChiCTR1900022902. Registered on 27 April 2019.
Source: Trials - Category: Research Source Type: clinical trials